12d
GlobalData on MSNTrevi’s Phase IIb chronic cough success spikes stock by 71%The company’s trial of Haduvio met its primary and secondary endpoints in reducing coughing fits across patients by 53%.
Dr. Duffy says asthma, reflux, post-nasal drip, and drugs like ACE inhibitors for blood pressure, cause the most coughs. GERD, or reflux, can cause coughing, although coughing can also cause GERD.
Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...
13d
Parade on MSNThe Unexpected Cough Remedy That Starts Working Almost ImmediatelyDealing with a constant cough can be downright miserable—especially if it’s at night when you’re trying to sleep. Even after ...
The New Haven, Conn., biopharmaceutical company shared positive topline results from a Phase 2a trial of Haduvio for the treatment of patients with refractory chronic cough. Haduvio met the primary ...
Trevi Therapeutics (TRVI) stock has rocketed up over 63% in the past week on news that recent clinical trials have shown promising results. The ...
Unlike normal cough, tuberculosis is usually accompanied by typical symptoms such as fever, shivering, night sweats, loss of ...
Haduvio met the primary endpoint with a statistically-significant reduction (p<0.0001) in 24-hour cough frequency with a 57% placebo-adjusted c ...
But there’s probably a good reason you have that cough — and it can tell you a lot about what’s going on in your body.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results